Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.38 in the prior trading day, CorMedix Inc (NASDAQ: CRMD) closed at $8.31, down -0.84%. In other words, the price has decreased by -$0.84 from its previous closing price. On the day, 1.35 million shares were traded. CRMD stock price reached its highest trading level at $8.56 during the session, while it also had its lowest trading level at $8.17.
Ratios:
Our goal is to gain a better understanding of CRMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 26, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.
On February 17, 2021, Needham started tracking the stock assigning a Buy rating and target price of $31.Needham initiated its Buy rating on February 17, 2021, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 31 ’24 when Mistry Erin bought 1,500 shares for $9.99 per share. The transaction valued at 14,985 led to the insider holds 52,011 shares of the business.
Hurlburt Elizabeth sold 140,027 shares of CRMD for $1,565,670 on Nov 14 ’24. The EVP now owns 45,397 shares after completing the transaction at $11.18 per share. On Nov 14 ’24, another insider, Hurlburt Elizabeth, who serves as the Officer of the company, bought 140,027 shares for $11.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 504227552 and an Enterprise Value of 458754464. For the stock, the TTM Price-to-Sale (P/S) ratio is 39.30 while its Price-to-Book (P/B) ratio in mrq is 8.19. Its current Enterprise Value per Revenue stands at 37.412 whereas that against EBITDA is -9.037.
Stock Price History:
Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $2.89. The 50-Day Moving Average of the stock is -20.38%, while the 200-Day Moving Average is calculated to be 28.40%.
Shares Statistics:
The stock has traded on average 1.16M shares per day over the past 3-months and 855890 shares per day over the last 10 days, according to various share statistics. A total of 60.68M shares are outstanding, with a floating share count of 59.81M. Insiders hold about 1.44% of the company’s shares, while institutions hold 31.41% stake in the company. Shares short for CRMD as of 1732838400 were 6891533 with a Short Ratio of 5.92, compared to 1730332800 on 6284633. Therefore, it implies a Short% of Shares Outstanding of 6891533 and a Short% of Float of 11.37.
